$275 Million Class Action Settlement To Benefit Consumers and Third-Party Payers Announced by End-Payer Plaintiffs in Prescription Generic Drug Case
Press Releases

$275 Million Class Action Settlement To Benefit Consumers and Third-Party Payers Announced by End-Payer Plaintiffs in Prescription Generic Drug Case

PHILADELPHIA, March 10, 2025 /PRNewswire/ --

avatar profile Olean Times Herald

Olean Times Herald


Local & Social